tyrosinyl-5'-AMP: RN given refers to S-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 169008 |
| MeSH ID | M0072142 |
| Synonym |
|---|
| adenylyl-tyrosine |
| TYA , |
| 6372-08-3 |
| [(2s)-2-amino-3-(4-hydroxyphenyl)propyl] [(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate |
| tyrosyl adenylate |
| (s)-5'-adenylic acid, mono(2-amino-3-(4-hydroxyphenyl)propyl) ester |
| tyrosinyl-5'-amp |
| 9-(5-o-{[2-amino-3-(4-hydroxyphenyl)propoxy](hydroxy)phosphoryl}pentofuranosyl)-9h-purin-6-amine |
| DTXSID70980163 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 8 (50.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.59) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 16 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||